AGC Inc., a Tokyo-based manufacturer of glass, chemicals, and high-tech materials, is investing approximately $100 million to expand the facilities of AGC Pharma Chemicals Europe S.L.U. (APCE), an AGC subsidiary in Spain engaged in the synthetic pharmaceutical CDMO business. A new building with a total floor area of 7,500 m2 will be constructed on the company’s site, increasing the current production capacity by 30%. The new facility is scheduled to start operation in 1H24.   APCE has in...